Jacobs Levy Equity Management
EVLO

Jacobs Levy Equity Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Jacobs Levy Equity Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,099
Closed -$116K – 1114
2020
Q3 		$116K Sell
1,099
-570
-34% -$51.9K ﹤0.01% 991
2020
Q2 		$164K Buy
+1,669
New +$146K ﹤0.01% 977

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's EVLO Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2020, closing a stake of 1,099 shares — an estimated $116K sold.

Jacobs Levy Equity Management first reported a position in EVLO in Q2 2020 and held it in 2 quarters. The position peaked at $164K in Q2 2020. 49 funds tracked by Wall St. Rank hold EVLO as of Q4 2020.

  • Jacobs Levy Equity Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 1,099 Evelo Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $116K.
  • Jacobs Levy Equity Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Evelo Biosciences, Inc. Common Stock position peaked at $164K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.